IDEAYA Biosciences press release ( IDYA ): Q1 GAAP EPS of -$1.11 misses by $0.12 . Revenue of $6.56M (-39.7% Y/Y) beats by $1.52M . Collaboration revenue was recognized for the performance obligations satisfied through March 31, 2026 related to the research and development services that are recognized over time under the Servier exclusive license agreement for darovasertib. As of March 31, 2026, t...
IDEAYA Biosciences press release ( IDYA ): Q1 GAAP EPS of -$1.11 misses by $0.12 . Revenue of $6.56M (-39.7% Y/Y) beats by $1.52M . Collaboration revenue was recognized for the performance obligations satisfied through March 31, 2026 related to the research and development services that are recognized over time under the Servier exclusive license agreement for darovasertib. As of March 31, 2026, the remaining balance for the research and development services performance obligations is $155.3 million related to the clinical development cost reimbursements anticipated under the license agreement that will be recognized as IDEAYA collaboration revenue over time as the research and development services are completed. More on IDEAYA Biosciences IDEAYA Biosciences, Inc. (IDYA) Discusses Topline Results from OptimUM-02 Trial Evaluating Darovasertib and Crizotinib in HLA-A2-Negative Metastatic Uveal Melanoma - Slideshow Ideaya Biosciences: Stock Buoyant On Good mUM Data - But Approval Not A Formality IDEAYA Biosciences, Inc. (IDYA) Discusses Topline Results from OptimUM-02 Trial Evaluating Darovasertib and Crizotinib in HLA-A2-Negative Metastatic Uveal Melanoma Transcript IDEAYA slips on delaying results from darovasertib uveal melanoma trial IDEAYA Biosciences GAAP EPS of -$0.94 beats by $0.03, revenue of $10.88M beats by $4.93M
Alphabet Inc. (NASDAQ:GOOGL) is one of the Best Quantum Computing Stocks to Buy and Hold for 10 Years. The company has made significant contributions to the quantum industry through a dedicated quantum team. For instance, Google has developed scalable hardware such as the Willow chip and superconducting qubits, alongside expansions into neutral atom qubits. On […]
Alphabet Inc. (NASDAQ:GOOGL) is one of the Best Quantum Computing Stocks to Buy and Hold for 10 Years. The company has made significant contributions to the quantum industry through a dedicated quantum team. For instance, Google has developed scalable hardware such as the Willow chip and superconducting qubits, alongside expansions into neutral atom qubits. On […]
Waters press release ( WAT ): Q1 Non-GAAP EPS of $2.70 beats by $0.39 . Revenue of $1.27B (+91.8% Y/Y) beats by $70M . Organic revenue for the first quarter of 2026 was $747 million, compared to $662 million for the first quarter of 2025, representing an increase of 13% as reported and 11% in constant currency. The Company is raising its full year 2026 organic constant currency revenue growth guid...
Waters press release ( WAT ): Q1 Non-GAAP EPS of $2.70 beats by $0.39 . Revenue of $1.27B (+91.8% Y/Y) beats by $70M . Organic revenue for the first quarter of 2026 was $747 million, compared to $662 million for the first quarter of 2025, representing an increase of 13% as reported and 11% in constant currency. The Company is raising its full year 2026 organic constant currency revenue growth guidance to 6.5% to 8.0% and now expects the acquired businesses to generate $3.035 billion of reported revenue in 2026 vs. $6.42B consensus (prior $6.405 billion to $6.455 billion) . The Company is also raising its full-year 2026 adjusted EPS guidance to $14.40 to $14.60 vs. $14.38 consensus (prior $14.30 to $14.50) , reflecting double-digit adjusted EPS growth. Second Quarter 2026 Financial Guidance: The Company expects second quarter 2026 organic constant currency revenue growth to be in the range of 6.0% to 8.0%. Including the impact of currency translation, second quarter 2026 organic reported revenue is expected to be in the range of $814 million to $829 million. The Company expects acquired business reported revenue for the second quarter 2026 to be approximately $802 million. Total Company reported revenue for the second quarter of 2026 is expected to be in the range of $1.616 billion to $1.631 billion vs. consensus of $1.62B . The Company expects second quarter 2026 adjusted EPS to be in the range of $2.95 to $3.05 vs. $3.00 consensus , which represents flat to 3.4% year-over-year adjusted EPS growth. More on Waters Waters: Doing Well, Acquired Activities Not So Much Waters Corporation (WAT) Presents at TD Cowen 46th Annual Health Care Conference Transcript Waters Corporation (WAT) Q4 2025 Earnings Call Transcript Waters Q1 2026 Earnings Preview Waters wins FDA nod for at-home cervical cancer screening kit
Microsoft Corporation (NASDAQ:MSFT) is pursuing quantum computing as a core long‑term pillar of its Azure cloud platform. The company is developing topological qubits based on Majorana physics, which are aimed at fault‑tolerant quantum computers with up to a million logical qubits on a single chip. The company also ranks among the Best Quantum Computing Stocks […]
Microsoft Corporation (NASDAQ:MSFT) is pursuing quantum computing as a core long‑term pillar of its Azure cloud platform. The company is developing topological qubits based on Majorana physics, which are aimed at fault‑tolerant quantum computers with up to a million logical qubits on a single chip. The company also ranks among the Best Quantum Computing Stocks […]
Oaktree Specialty Lending press release ( OCSL ): Q2 Non-GAAP EPS of -$0.22 misses by $0.59 . Total investment income of $70.4M (-9.3% Y/Y) misses by $4.06M . Net asset value (“NAV”) per share was $15.69 as of March 31, 2026, down as compared with $16.30 as of December 31, 2025 More on Oaktree Specialty Lending Oaktree Specialty Lending: Deep Discount To NAV And A 14.6% Dividend Yield Oaktree Spec...
Oaktree Specialty Lending press release ( OCSL ): Q2 Non-GAAP EPS of -$0.22 misses by $0.59 . Total investment income of $70.4M (-9.3% Y/Y) misses by $4.06M . Net asset value (“NAV”) per share was $15.69 as of March 31, 2026, down as compared with $16.30 as of December 31, 2025 More on Oaktree Specialty Lending Oaktree Specialty Lending: Deep Discount To NAV And A 14.6% Dividend Yield Oaktree Specialty Lending: BDC Market Sell-Off Likely Overdone, Hold The Hidden Math Behind Ares Capital Beating Oaktree Specialty Lending Oaktree Specialty Lending FQ2 2026 Earnings Preview Oaktree signals stable earnings and $314M new investment deployment while navigating AI, credit market shifts
Henry Schein press release ( HSIC ): Q1 Non-GAAP EPS of $1.32 beats by $0.10 . Revenue of $3.37B (+6.3% Y/Y) beats by $30M . Total net sales for the quarter were $3.4 billion, an increase of 6.3% compared to the first quarter of 2025 and reflects 2.5% internal sales growth, 0.7% sales growth from acquisitions, and a 3.1% increase resulting from foreign currency exchange. 2026 Guidance: 2026 non-GA...
Henry Schein press release ( HSIC ): Q1 Non-GAAP EPS of $1.32 beats by $0.10 . Revenue of $3.37B (+6.3% Y/Y) beats by $30M . Total net sales for the quarter were $3.4 billion, an increase of 6.3% compared to the first quarter of 2025 and reflects 2.5% internal sales growth, 0.7% sales growth from acquisitions, and a 3.1% increase resulting from foreign currency exchange. 2026 Guidance: 2026 non-GAAP diluted EPS attributable to Henry Schein, Inc. is unchanged and expected to be $5.23 to $5.37 vs $5.32 consensus 2026 total sales growth is unchanged and expected to be approximately 3% to 5% over 2025. 2026 Adjusted EBITDA3 is unchanged and expected to grow mid-single digits compared with 2025. More on Henry Schein Henry Schein: Still A Buy - But Caution Is Warranted Henry Schein, Inc. (HSIC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Henry Schein, Inc. (HSIC) Presents at Leerink Global Healthcare Conference 2026 Transcript Henry Schein Q1 2026 Earnings Preview Henry Schein shrinks board as long-serving chairman retires
Our cartoonist on a weekend of genuine excitement at the top and bottom of the English top-flight table Buy a cartoon here | His favourites from 2025 And his latest book, Chaos in the Box: get it now Continue reading...
Our cartoonist on a weekend of genuine excitement at the top and bottom of the English top-flight table Buy a cartoon here | His favourites from 2025 And his latest book, Chaos in the Box: get it now Continue reading...
Staffers at Google DeepMind's headquarters have voted to unionize in an effort to prevent the AI firm's technology from being used by Israel and the US military. In a letter to Google management on Tuesday, employees requested that the Communication Workers Union (CWU) and Unite the Union be recognized as joint representatives, with 98 percent of CWU members at DeepMind voting in support of the mo...
Staffers at Google DeepMind's headquarters have voted to unionize in an effort to prevent the AI firm's technology from being used by Israel and the US military. In a letter to Google management on Tuesday, employees requested that the Communication Workers Union (CWU) and Unite the Union be recognized as joint representatives, with 98 percent of CWU members at DeepMind voting in support of the move. "We don't want our AI models complicit in violations of international law, but they already are aiding Israel's genocide of Palestinians," an unnamed DeepMind employee said in a statement shared by the CWU. "Even if our work is only used for ad … Read the full story at The Verge.
Archer-Daniels-Midland press release ( ADM ): Q1 Non-GAAP EPS of $0.71 beats by $0.05 . Revenue of $20.49B (+1.5% Y/Y) misses by $860M . 2026 Outlook: ADM now expects 2026 adjusted EPS1,2 of approximately $4.15 to $4.70, up from the prior adjusted EPS1,2 guidance range of $3.60 to $4.25 (vs. consensus of $4.23) The updated outlook assumes continued progress related to company priorities and reflec...
Archer-Daniels-Midland press release ( ADM ): Q1 Non-GAAP EPS of $0.71 beats by $0.05 . Revenue of $20.49B (+1.5% Y/Y) misses by $860M . 2026 Outlook: ADM now expects 2026 adjusted EPS1,2 of approximately $4.15 to $4.70, up from the prior adjusted EPS1,2 guidance range of $3.60 to $4.25 (vs. consensus of $4.23) The updated outlook assumes continued progress related to company priorities and reflects expected earnings improvement primarily in ADM’s crushing and ethanol businesses as a result of the finalization of the 2026 and 2027 renewable volume obligations (“RVO”) under the U.S. Renewable Fuels Standard in March of 2026 External factors will continue to be monitored, and include consumer trends, energy costs, supply chain dislocations, ethanol developments, and evolving global trade and tariff conditions Capital expenditures continue to be projected to be in the range of $1.3 to $1.5 billion More on Archer-Daniels-Midland Archer-Daniels-Midland: Policy Wins Don't Fix This Dividend King's Valuation Archer-Daniels-Midland Company (ADM) Presents at Bank of America 2026 Global Agriculture and Materials Conference Transcript Archer-Daniels-Midland: Dividend King Stability Meets Biofuel Policy Uncertainty Archer-Daniels-Midland Q1 2026 Earnings Preview U.S. struggles to define ‘ultraprocessed foods’ as Kennedy pushes crackdown
Ingredion press release ( INGR ): Q1 Non-GAAP EPS of $2.34 misses by $0.13 . Revenue of $1.79B (-1.1% Y/Y) in-line. Adjusting full-year guidance for reported EPS to be in the range of $9.60 to $10.30 and adjusted EPS to be in the range of $10.45 to $11.15 vs. $11.33 consensus Shares -4% PM. More on Ingredion Ingredion Incorporated (INGR) Presents at Consumer Analyst Group of New York Conference 20...
Ingredion press release ( INGR ): Q1 Non-GAAP EPS of $2.34 misses by $0.13 . Revenue of $1.79B (-1.1% Y/Y) in-line. Adjusting full-year guidance for reported EPS to be in the range of $9.60 to $10.30 and adjusted EPS to be in the range of $10.45 to $11.15 vs. $11.33 consensus Shares -4% PM. More on Ingredion Ingredion Incorporated (INGR) Presents at Consumer Analyst Group of New York Conference 2026 - Slideshow Ingredion Incorporated (INGR) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript Ingredion: Defensive, High-Yield, Undervalued, And Transforming For Growth Ingredion Q1 2026 Earnings Preview Ingredion names Jason Payant interim CFO effective April 1
Integra LifeSciences ( IART ) said Tuesday that Stuart Essig, chairman of Integra’s board of directors, has been appointed president and chief executive officer, effective May 1, 2026. Essig brings more than 30 years of experience in the medical technology and healthcare industries and will continue to serve as chairman. He succeeds Mojdeh Poul, who is pursuing other opportunities. More on Integra...
Integra LifeSciences ( IART ) said Tuesday that Stuart Essig, chairman of Integra’s board of directors, has been appointed president and chief executive officer, effective May 1, 2026. Essig brings more than 30 years of experience in the medical technology and healthcare industries and will continue to serve as chairman. He succeeds Mojdeh Poul, who is pursuing other opportunities. More on Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation (IART) Q4 2025 Earnings Call Transcript Integra LifeSciences Holdings Corporation 2025 Q4 - Results - Earnings Call Presentation Integra LifeSciences Holdings Corporation Q1 2026 Earnings Preview Integra outlines $1.66B-$1.7B 2026 revenue target as new operating model drives transformation Seeking Alpha’s Quant Rating on Integra LifeSciences Holdings Corporation
Oil prices have risen sharply due to the war with Iran. Brent oil, the global benchmark, recently traded above $110 a barrel amid continued supply disruptions in the Middle East. The price of Brent has surged nearly 90% this year. Here is a look at whether investors should buy, sell, or hold Chevron (NYSE: CVX) stock, given the current price of crude oil. Image source: The Motley Fool. Continue re...
Oil prices have risen sharply due to the war with Iran. Brent oil, the global benchmark, recently traded above $110 a barrel amid continued supply disruptions in the Middle East. The price of Brent has surged nearly 90% this year. Here is a look at whether investors should buy, sell, or hold Chevron (NYSE: CVX) stock, given the current price of crude oil. Image source: The Motley Fool. Continue reading